The lag in funding extends far beyond D.E.I. initiatives, affecting almost every area of science: chemistry, computing, ...

In a new clinical study, researchers from the Texas Biomedical Device Center (TxBDC) at The University of Texas at Dallas ...

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

Syantra, Inc., has recently completed new patent filings that expand previous work in cancer molecular diagnostics to encompass new drug targets and therapeutics.

Researchers have developed a technology that delivers RNA to damaged neurons and stimulates regrowth - paving the way for ...

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...